Literature DB >> 32587079

Implementation and microbiological stability of dose-banded ganciclovir infusion bags prepared in series by a robotic system.

Irene Krämer1, Matteo Federici1.   

Abstract

OBJECTIVES: The implementation of dose-banding (DB) in centralised, pharmacy-based cytotoxic drug preparation units allows the preparation of standardised doses in series. The aim of this study was to evaluate the feasibility of DB for the prescribing of ganciclovir (GV) infusion solutions and to investigate the microbiological stability of dose-banded, automatically prepared ready-to-administer GV infusion bags by media-fill simulation tests and sterility tests.
METHODS: The frequency of prescription of GV doses was retrospectively analysed before and after implementing the DB scheme. Four dose-ranges or 'bands' and the corresponding standard doses (250, 300, 350, 400 mg) were identified. The maximum variance was set at ±10% of the individually prescribed dose. The aseptic preparation of a series of GV infusion bags was simulated with double strength tryptic soy broth as growth medium and prefilled 0.9% NaCl polyolefin infusion bags as primary packaging materials. The simulation process was performed with the APOTECAchemo robot on five consecutive days. In total, 50 infusion bags were filled, incubated and stored for 12 weeks at room temperature. The media-filled bags were visually inspected for turbidity after 2, 4, 8, 10 and 12 weeks. Following incubation, growth promotion tests were performed. During the simulation tests, airborne contamination was monitored with settle plates and microbial surface contamination with contact plates. Pooled sterility tests were performed for a series of 10 standard GV infusion bags after a 12-week storage period under refrigeration (2 °C-8 °C).
RESULTS: After implementation of the DB scheme, about 60% of the prescribed GV doses were prepared as standard preparations by the robotic system. The number of different GV doses was reduced by 61.8% (76 vs 29). None of the 50 media-filled bags showed turbidity after a storage period of 12 weeks, indicating the absence of microorganisms. The environmental monitoring with settle/contact plates matched the recommended limits set for cleanroom Grade A zones, except in the loading area of the robot. Media fills used for the sterility tests remained clear during the incubation period, thereby revealing sterility. Positive growth promotion tests proved the process's reliability.
CONCLUSIONS: A DB scheme for prescribing and preparation of standard GV infusion bags was successfully implemented. Microbiological tests of aseptic preparation of infusion bags in series by the APOTECAchemo robot revealed an adequate level of sterility and a well-controlled aseptic procedure. The sterility was maintained over extended storage periods, thereby encouraging extended beyond-use dating. © European Association of Hospital Pharmacists 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  dose-banding; ganciclovir; media-fill tests; microbiological stability; robotic system

Year:  2018        PMID: 32587079      PMCID: PMC7335619          DOI: 10.1136/ejhpharm-2018-001745

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  16 in total

1.  Reliability of chemotherapy preparation processes: Evaluating independent double-checking and computer-assisted gravimetric control.

Authors:  Laurent Carrez; Lucie Bouchoud; Sandrine Fleury-Souverain; Christophe Combescure; Ludivine Falaschi; Farshid Sadeghipour; Pascal Bonnabry
Journal:  J Oncol Pharm Pract       Date:  2016-07-09       Impact factor: 1.809

2.  Paving the Way for Dose Banding of Chemotherapy: An Analytical Approach.

Authors:  Heike Reinhardt; Rainer Trittler; Alison G Eggleton; Stefan Wöhrl; Thomas Epting; Marion Buck; Sabine Kaiser; Daniel Jonas; Justus Duyster; Manfred Jung; Martin J Hug; Monika Engelhardt
Journal:  J Natl Compr Canc Netw       Date:  2017-04       Impact factor: 11.908

3.  Dose-banding of carboplatin: rationale and proposed banding scheme.

Authors:  Sabine Kaestner; Graham Sewell
Journal:  J Oncol Pharm Pract       Date:  2007-06       Impact factor: 1.809

4.  Robot-assisted preparation of oncology drugs: the role of nurses.

Authors:  Elisabetta Palma; Celestino Bufarini
Journal:  Int J Pharm       Date:  2012-09-24       Impact factor: 5.875

5.  Stability of ganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injection over 35 days.

Authors:  J Parasrampuria; L C Li; A H Stelmach; T R Sykes; G A Gordon
Journal:  Am J Hosp Pharm       Date:  1992-01

6.  ASHP guidelines on preventing medication errors with chemotherapy and biotherapy.

Authors:  Barry Goldspiel; James M Hoffman; Niesha L Griffith; Susan Goodin; Robert DeChristoforo; Capt Michael Montello; Judy L Chase; Sylvia Bartel; Jharana Tina Patel
Journal:  Am J Health Syst Pharm       Date:  2015-04-15       Impact factor: 2.637

7.  Long-term stability of ganciclovir in polypropylene containers at room temperature.

Authors:  Nicolas Guichard; Pascal Bonnabry; Serge Rudaz; Sandrine Fleury-Souverain
Journal:  J Oncol Pharm Pract       Date:  2017-01-01       Impact factor: 1.809

8.  Performance evaluation of the compounding robot, APOTECAchemo, for injectable anticancer drugs in a Japanese hospital.

Authors:  Takuya Iwamoto; Takuya Morikawa; Miki Hioki; Hirofumi Sudo; Demis Paolucci; Masahiro Okuda
Journal:  J Pharm Health Care Sci       Date:  2017-04-24

9.  Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents.

Authors:  E Chatelut; M L White-Koning; R Hj Mathijssen; F Puisset; S D Baker; A Sparreboom
Journal:  Br J Cancer       Date:  2012-08-28       Impact factor: 7.640

10.  Investigating the potential impact of dose banding for systemic anti-cancer therapy in the paediatric setting based on pharmacokinetic evidence.

Authors:  Melanie White-Koning; Caroline Osborne; Angelo Paci; Alan V Boddy; Etienne Chatelut; Gareth J Veal
Journal:  Eur J Cancer       Date:  2018-01-12       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.